Major study milestone highlights START's commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials SAN ANTONIO, May 15, 2025 /PRNewswire/ -- The ...
BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing's proprietary platforms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results